Clinical Trial Update: Transcranial Magnetic Stimulation in Smokers: an Examination of Mediating Neural Pathways. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing transcranial magnetic stimulation in smokers and its neural mediating pathways has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Snippet

Sponsor: Kent State University | Conditions: Smoking | Phase 2 | Status: COMPLETED